An Open Label Dose Titration of Sevelamer Carbonate Tabs 3 Times a Day in Hyperphosphatemic CKD Patients Not On Dialysis

PHASE3CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

January 31, 2007

Study Completion Date

March 31, 2007

Conditions
Chronic Kidney DiseaseHyperphosphatemia
Interventions
DRUG

Sevelamer carbonate (Renvela®)

Sevelamer Carbonate Tablets Dosed Three Times A Day

Trial Locations (25)

3050

The Royal Melbourne Hospital, Department of Nephrology, Parkville

3121

Melbourne Renal Research Group, Epworth Medical Centre, Richmond

4102

Nephrology Department, Princess Alexandra Hospital, Wooloongabba

5011

Renal Unit, The Queen Elizabeth Hospital, Woodville

7250

Renal Research Unit, Launceston General Hospital, Launceston

75908

George Pompidou, European Hospital, Paris

DK-9100

Nyremedicinsk Afdeling, Medicinerhuset, Aalborg

DK-2100

Medicinsk Afdeling, Copenhagen

DK 3400

Nefrologisk Afdeling, Hilleroed Sygehus, Hilleroed

DK-4000

Medicinsk Afdeling, nefrologisk, Roskilde Sygehus, Roskilde

D-52074

Universitätsklinikum Aachen, Medizinsche Klinik II, Aachen

D-20246

Universitätsklinikum Hamburg Eppendorf, Hamburg

D-69115

Heimdialysezentrum, Heidelberg

D-90431

KfH Nierenzentrum, Nuremberg

D 42653

Stadt Klinken Solingen, Klinik für Nephrologie und Allgemeine Innere Medizin, Solingen

D 78054

Nephrologisches Zentrum, Villingen-Schwenningen

B15 2PR

Birmingham Hospital, Queen Elizabeth Medical Centre, Birmingham

BS10 5NB

Southmead Hospital, Bristol

CB2 2QQ

Addenbrooke's Dialysis Centre, Cambridge

LE5 4PW

Leicester General Hospital, Leicester

E1 1BB

Renal Department, The Royal London Hospital, London

SE1 9RT

Renal & Urology SDU Offices, London

M13 9WL

Renal Dialysis Unit, Manchester Royal Infirmary, Manchester

M6 8HD

Department of Renal Medicine, Hope Hospital, Manchester

PO6 3RY

Renal Unit, Queen Alexandra Hospital, Portsmouth

All Listed Sponsors
lead

Genzyme, a Sanofi Company

INDUSTRY

NCT00681941 - An Open Label Dose Titration of Sevelamer Carbonate Tabs 3 Times a Day in Hyperphosphatemic CKD Patients Not On Dialysis | Biotech Hunter | Biotech Hunter